A 3D microfluidic BBB model is based on iPSCs from patients with AD mimicked vascular damage as an increased BBB permeability, a reduction in TJs and AJs, and an increased expression of the matrix-metalloproteinase-2 (MMP2) (Shin et al., 2019). This evidence concerns the gene MMP2 and Alzheimer disease.